313 related articles for article (PubMed ID: 31375581)
1. Endosomal Toll-Like Receptors Mediate Enhancement of Interleukin-17A Production Triggered by Epstein-Barr Virus DNA in Mice.
Shehab M; Sherri N; Hussein H; Salloum N; Rahal EA
J Virol; 2019 Oct; 93(20):. PubMed ID: 31375581
[TBL] [Abstract][Full Text] [Related]
2. Endosomal Toll-Like Receptors (TLRs) mediate enhancement of IL-17A production triggered by Epstein-Barr virus (EBV) DNA in mice.
Shehab M; Jammaz R; Salloum N; Rahal EA
J Infect Dev Ctries; 2018 Feb; 12(2.1):26S. PubMed ID: 31805001
[TBL] [Abstract][Full Text] [Related]
3. Epstein-Barr virus DNA modulates regulatory T-cell programming in addition to enhancing interleukin-17A production via Toll-like receptor 9.
Salloum N; Hussein HM; Jammaz R; Jiche S; Uthman IW; Abdelnoor AM; Rahal EA
PLoS One; 2018; 13(7):e0200546. PubMed ID: 29995930
[TBL] [Abstract][Full Text] [Related]
4. The Effects of Endosomal Toll-like Receptor Inhibitors in an EBV DNA-Exacerbated Inflammatory Bowel Disease Mouse Model.
Karout I; Salhab Z; Sherri N; Bitar ER; Borghol AH; Sabra H; Kassem A; Osman O; Alam C; Znait S; Assaf R; Fadlallah S; Jurjus A; Hashash JG; Rahal EA
Viruses; 2024 Apr; 16(4):. PubMed ID: 38675965
[TBL] [Abstract][Full Text] [Related]
5. Epstein-Barr Virus DNA Exacerbates Arthritis in a Mouse Model via Toll-like Receptor 9.
Sherri N; Assaf R; Bitar ER; Znait S; Borghol AH; Kassem A; Rahal EA
Int J Mol Sci; 2024 Apr; 25(9):. PubMed ID: 38731877
[TBL] [Abstract][Full Text] [Related]
6. Epstein-Barr Virus and Human herpes virus 6 Type A DNA Enhance IL-17 Production in Mice.
Rahal EA; Hajjar H; Rajeh M; Yamout B; Abdelnoor AM
Viral Immunol; 2015 Jun; 28(5):297-302. PubMed ID: 25870901
[TBL] [Abstract][Full Text] [Related]
7. Epstein-Barr Virus DNA Exacerbates Colitis Symptoms in a Mouse Model of Inflammatory Bowel Disease.
Andari S; Hussein H; Fadlallah S; Jurjus AR; Shirinian M; Hashash JG; Rahal EA
Viruses; 2021 Jun; 13(7):. PubMed ID: 34210024
[TBL] [Abstract][Full Text] [Related]
8. An IL-17A-centric response to Epstein-Barr virus DNA mediated by dendritic Cell-T cell interactions.
Shehab M; Hussein H; Fadlallah S; Rahal EA
Front Mol Biosci; 2024; 11():1243366. PubMed ID: 38638687
[No Abstract] [Full Text] [Related]
9. Increased expression of Toll-like receptors 7 and 9 in myasthenia gravis thymus characterized by active Epstein-Barr virus infection.
Cavalcante P; Galbardi B; Franzi S; Marcuzzo S; Barzago C; Bonanno S; Camera G; Maggi L; Kapetis D; Andreetta F; Biasiucci A; Motta T; Giardina C; Antozzi C; Baggi F; Mantegazza R; Bernasconi P
Immunobiology; 2016 Apr; 221(4):516-27. PubMed ID: 26723518
[TBL] [Abstract][Full Text] [Related]
10. Epstein-Barr virus large tegument protein BPLF1 contributes to innate immune evasion through interference with toll-like receptor signaling.
van Gent M; Braem SG; de Jong A; Delagic N; Peeters JG; Boer IG; Moynagh PN; Kremmer E; Wiertz EJ; Ovaa H; Griffin BD; Ressing ME
PLoS Pathog; 2014 Feb; 10(2):e1003960. PubMed ID: 24586164
[TBL] [Abstract][Full Text] [Related]
11. An Epstein-Barr Virus MicroRNA Blocks Interleukin-1 (IL-1) Signaling by Targeting IL-1 Receptor 1.
Skinner CM; Ivanov NS; Barr SA; Chen Y; Skalsky RL
J Virol; 2017 Nov; 91(21):. PubMed ID: 28794034
[TBL] [Abstract][Full Text] [Related]
12. Epstein-Barr virus lytic infection promotes activation of Toll-like receptor 8 innate immune response in systemic sclerosis monocytes.
Farina A; Peruzzi G; Lacconi V; Lenna S; Quarta S; Rosato E; Vestri AR; York M; Dreyfus DH; Faggioni A; Morrone S; Trojanowska M; Farina GA
Arthritis Res Ther; 2017 Feb; 19(1):39. PubMed ID: 28245863
[TBL] [Abstract][Full Text] [Related]
13. Host factors associated with the kinetics of Epstein-Barr virus DNA load in patients with primary Epstein-Barr virus infection.
Nakai H; Kawamura Y; Sugata K; Sugiyama H; Enomoto Y; Asano Y; Ihira M; Ohashi M; Kato T; Yoshikawa T
Microbiol Immunol; 2012 Feb; 56(2):93-8. PubMed ID: 22150751
[TBL] [Abstract][Full Text] [Related]
14. Effect of Epstein-Barr Virus DNA on the Incidence and Severity of Arthritis in a Rheumatoid Arthritis Mouse Model.
Fadlallah S; Hussein H; Jallad MA; Shehab M; Jurjus AR; Matar GM; Rahal EA
Front Immunol; 2021; 12():672752. PubMed ID: 34040613
[TBL] [Abstract][Full Text] [Related]
15. Endosomal Toll-Like Receptors 7 and 9 Cooperate in Detection of Murine Gammaherpesvirus 68 Infection.
Bussey KA; Murthy S; Reimer E; Chan B; Hatesuer B; Schughart K; Glaunsinger B; Adler H; Brinkmann MM
J Virol; 2019 Feb; 93(3):. PubMed ID: 30429335
[TBL] [Abstract][Full Text] [Related]
16. Immune activation suppresses initiation of lytic Epstein-Barr virus infection.
Ladell K; Dorner M; Zauner L; Berger C; Zucol F; Bernasconi M; Niggli FK; Speck RF; Nadal D
Cell Microbiol; 2007 Aug; 9(8):2055-69. PubMed ID: 17419714
[TBL] [Abstract][Full Text] [Related]
17. Regulation and dysregulation of Epstein-Barr virus latency: implications for the development of autoimmune diseases.
Niller HH; Wolf H; Minarovits J
Autoimmunity; 2008 May; 41(4):298-328. PubMed ID: 18432410
[TBL] [Abstract][Full Text] [Related]
18. The influence of toll-like receptor stimulation on expression of EBV lytic genes.
Siennicka J; Trzcińska A; Cześcik A; Dunal-Szczepaniak M; Lagosz B
Pol J Microbiol; 2013; 62(3):237-42. PubMed ID: 24459828
[TBL] [Abstract][Full Text] [Related]
19. Aberrant Epstein-Barr virus persistence in HIV carriers is characterized by anti-Epstein-Barr virus IgA and high cellular viral loads with restricted transcription.
Stevens SJ; Smits PH; Verkuijlen SA; Rockx DA; van Gorp EC; Mulder JW; Middeldorp JM
AIDS; 2007 Oct; 21(16):2141-9. PubMed ID: 18090040
[TBL] [Abstract][Full Text] [Related]
20. Epstein-Barr virus load and immune activation in human immunodeficiency virus type 1-infected patients.
Petrara MR; Cattelan AM; Zanchetta M; Sasset L; Freguja R; Gianesin K; Cecchetto MG; Carmona F; De Rossi A
J Clin Virol; 2012 Mar; 53(3):195-200. PubMed ID: 22209290
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
